Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
September 2013 MS eNEWS
Moving the next generation forward

Society connects research fellows with key mentors

Dr. Sabeen Lulu’s best friend was diagnosed with multiple sclerosis while Sabeen was in med school. Now, through a Society-funded Sylvia Lawry Physician Fellowship, she’s working with MS research leader Dr. Emmanuelle Waubant to design studies that will look into the challenges faced by children living with the disease.

Dr. Megan Langille met dozens of children living with MS while in training as a pediatric neurology resident. Her experience moved her to pursue a Clinical Care Physician Fellowship, working with neurologist Dr. Lilyana Amezcua to better serve underinsured children with MS.

Meet Sabeen and Megan on MSconnection.org

Society scholarships for students affected by MS

Read "A great education with MS” in new Momentum

Support these and other programs through employee giving


Why doesn't all MS get worse?

Why doesn’t all MS get worse?


facebook twitter youtube flickr linkedin


 Donate Now

Dr. Jonah Chan Breakthrough MS researcher recognized

Neurologist Jonah Chan, PhD, spends every day moving toward a single goal: To stimulate brain repair in people living with multiple sclerosis. Dr. Chan, one of the Society’s Harry Weaver Neuroscience Scholars, was just awarded the first Barancik Prize for Innovation in MS Research to recognize his cutting-edge work in this area.

Read more about Dr. Chan’s exciting research


New immune therapy on horizonNew immune therapy on the horizon

A significant decrease in disease activity was seen in people with relapsing MS treated in an early phase trial with a new experimental MS therapy (ATX-MS-1467). The European biotech company Apitope, which developed the drug, was one of the Society’s first commercial partnerships aimed at providing seed money to speed treatments to people with MS.

Read about how ATX-MS-1467 works


More MS News

Sep 16: Investigators recruiting 1,410 people with relapsing MS for study of oral RPC1063

Sep 11: More evidence that MS damage to brain’s gray matter may occur early in disease process

Read more about these and other recent reports

This communication is partially sponsored through the generous support of
Biogen Idec; Genzyme, a Sanofi company; Novartis Pharmaceuticals Corporation; and Teva Neuroscience, Inc.
MS Active Source Genzyme, a Sanofi company Novartis Teva Neuroscience, Inc.
Join a Walk MS Event       Join a Bike MS Event      Shop at the Society Store

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our website.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to   .
To ensure that you continue to receive our emails, please add us to your address book.